Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00537758 · ClinicalTrials.gov registry record · NA

Treatment for Obesity and Binge Eating Disorder

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
125
Enrollment target

NCT00537758: Completed NA study, sponsored by Yale University.

NCT00537758 is a NA study that has completed, run by Yale University. The registered enrollment target is 125 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00537758, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target

Study Summary

This study is a test of cognitive behavioral therapy(CBT) and behavioral weight loss (BWL) treatments for obese patients with binge eating disorder (BED). The study involves a comparison of three treatment conditions: (1) CBT; (2) BWL, and (3) a sequential (two-part) treatment consisting of CBT followed by BWL.

Interventions

  • BEHAVIORAL Cognitive Behavior Therapy
  • BEHAVIORAL CBT and BWL
  • BEHAVIORAL Behavioral Weight Loss Treatment

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2002-07
Phase NA
Yale University

1,492 total trials

What the finished NCT00537758 record still lists

NCT00537758 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 3 interventions - of which Cognitive Behavior Therapy is the first listed.

NCT00537758 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00537758 about?

NCT00537758 is a clinical study titled "Treatment for Obesity and Binge Eating Disorder". This study is a test of cognitive behavioral therapy(CBT) and behavioral weight loss (BWL) treatments for obese patients with binge eating disorder (BED). The study involves a comparison of three treatment conditions: (1) CBT; (2) BWL, and (3) a sequential (two-part) treatment consisting of CBT foll...

What is the current status of trial NCT00537758?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2002-07.

What interventions are being tested in trial NCT00537758?

The interventions under investigation include: Cognitive Behavior Therapy (BEHAVIORAL), CBT and BWL (BEHAVIORAL), Behavioral Weight Loss Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT00537758?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00537758's enrollment target sits among peer trials

125 753rd of 2000 higher than 1,243 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00537758, the US trial registry maintained by the National Library of Medicine. NCT00537758 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.